Yseop automates and translates data into actionable language, enabling the simplification of once complex workflows.
Yseop’s AI-based technologies generate core elements of specialist medical reports, including clinical study reports (CSR), patient narratives, and more.
Deliver highly accurate narratives by automating parts of the preclinical document review cycle.
Tim Martin, Executive VP of Product & Development at Yseop was recently featured in Forbes discussing AI regulation and the EU AI Act.
Listen to the next episode of AI Uncovered with Derek Kerton.
Without a doubt, advanced AI technologies are reimagining the future of medical writing. Historically, medical writers have been faced with inefficient, monotonous processes and have been seeking a solution to save time and ensure accuracy. Enter generative AI, which uses Large Language Models (LLMs) and advanced machine learning to create human-like text, pulling from existing data and experiences to generate new content.
Listen to the next episode of AI Uncovered with Daniel O’Mahony.
Natural language generation (NLG) is a critical piece of AI. Specifically, NLG is a subsection of Natural Language Processing (NLP). NLG software turns structured data into written reports, providing explanations and narratives at a rapid pace. We’ve seen many advancements stemming from NLG. In this blog post, we’ll discuss what’s new in natural language generation in AI.
Yseop is thrilled to announce that we have been nominated for The World Technology Leader Award. We are in the company of prestigious nominees including OpenAI, BMW, and BASF.
A recent study in JAMA Internal Medicine compared physician versus AI chatbot responses to patient’s questions asked on a public social media forum. Tim Martin, Yseop’s Vice president of Product and Development was featured in USA Today discussing this topic further.
In this blog post, we’ve highlighted the latest generative AI trends, updates and news articles from the past month.
The latest AI solutions can expedite the drug discovery process and ensure accuracy in life sciences. Recently, Yseop’s CEO, Emmanuel Walckenaer was featured in FierceElectronics discussing generative AI trends and benefits in the drug discovery process.
Generative AI in pharma is particularly gaining momentum, with many leading companies in life sciences already utilizing AI solutions and innovative technologies to increase productivity and efficiency across the board.
